Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Abstract Text:

Satoshi Suzuki,Yasuchika Takeishi,Takeshi Niizeki,Yo Koyama,Tatsuro Kitahara,Toshiki Sasaki,Mina Sagara,Isao Kubota,Satoshi Suzuki,Yasuchika Takeishi,Takeshi Niizeki,Yo Koyama,Tatsuro Kitahara,Toshiki Sasaki,Mina Sagara,Isao Kubota,Satoshi Suzuki,Yasuchika Takeishi,Takeshi Niizeki,Yo Koyama,Tatsuro Kitahara,Toshiki Sasaki,Mina Sagara,Isao Kubota,

BACKGROUND: Pentraxin 3 (PTX3) is a novel inflammatory marker produced by endothelial cells, smooth muscle cells, and macrophages. The purpose of the present study was to examine the clinical significance of plasma PTX3 levels in patients with heart failure. METHODS: We measured the plasma PTX3 levels in 196 patients with heart failure and 60 control subjects without heart failure by sandwich enzyme-linked immunosorbent assay. Patients were prospectively followed during a median follow-up period of 655 days with the end points of cardiac death or progressive heart failure requiring rehospitalization. RESULTS: Plasma PTX3 concentrations were higher in patients with heart failure than in control subjects (P < .0001) and increased as the severity of New York Heart Association functional class advanced (P < .0001). A total of 63 cardiac events occurred during a follow-up period, and cardiac event-free rate was markedly lower in patients with high PTX3 levels than in those with normal PTX3 levels (44.7% vs 89.2%, P < .0001). The multivariate Cox proportional hazard analysis demonstrated that the plasma PTX3 level, but not the high-sensitive C-reactive protein, was the independent predictor of cardiac events (hazard ratio 1.20, 95% CI 1.03-1.40, P = .0162). Patients were divided into 4 groups based on plasma PTX3 values from first to fourth quartile. The highest fourth quartile of plasma PTX3 levels was associated with the highest risk of cardiac events (9.23-fold compared with the first quartile). CONCLUSIONS: The plasma PTX3 level provides important prognostic information for the risk stratification of patients with heart failure.

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Publishing Authors By Initials

S Suzuki,Y Takeishi,T Niizeki,Y Koyama,T Kitahara,T Sasaki,M Sagara,I Kubota,S Suzuki,Y Takeishi,T Niizeki,Y Koyama,T Kitahara,T Sasaki,M Sagara,I Kubota,S Suzuki,Y Takeishi,T Niizeki,Y Koyama,T Kitahara,T Sasaki,M Sagara,I Kubota,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: American heart journal

VOLUME: 155

Page Numbers: 75-81

Journal Abbreviation: Am. Heart J.

ISSN: 1097-6744

DAY: 27

MONTH: 09

YEAR: 2007

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 370465

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure.

AFFILIATION: Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Am Heart J

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure Related Publications

• A catalytically active molecularly imprinted polymer that mimics peroxidase based on hemin: application to the determination of p-aminophenol.
• A nonfunctioning single nucleotide polymorphism in olfactory receptor gene family is associated with the forced expiratory volume in the first second/the forced vital capacity values of pulmonary function test in a Japanese population.
• A novel anti-cancer substance, MK615, from ume, a variety of Japanese apricot, inhibits growth of hepatocellular carcinoma cells by suppressing Aurora A kinase activity.
• Activities in the frontal cortex and gait performance are modulated by preparation. An fNIRS study.
• An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy.
• An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
• Anti-cook book approach, pro-standardized treatment parameters.
• Azelnidipine inhibits H2O2-induced cell death in neonatal rat cardiomyocytes.
• Bladder evisceration in a child with antenatally detected gastroschisis: Outcome of bladder function.
• C-Reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation.
• Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: effects of age, gender, and physiologic characteristics.
• Dynamic light scattering from dilute suspensions of thin discs and thin rods as limiting forms of cylinder, ellipsoid and ellipsoidal shell of revolution.
• Echo canceller ensuring further reduction in residual echo.
• Electrochemical and spectroscopic characterization of the interaction between DNA and Cu(II)-naringin complex.
• Elevated serum fibrin-monomer levels are associated with high long-term cerebrovascular event rates in acute ischemic stroke patients.
• Eosinophilic pustular folliculitis associated with pulmonary eosinophilia.
• Experience of retroperitoneoscopic adrenalectomy in 195 patients with primary aldosteronism.
• History of the development of intraoperative spinal cord monitoring.
• Laparoscopic splenectomy for recurrent splenic cyst after laparoscopic marsupialization.
• Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels.
• Localized linear IgA disease showing contact dermatitis-like eruption.
• Needlescopic Cholecystectomy Versus Needlescope-assisted Laparoscopic Cholecystectomy.
• Nonstationary chaotic oscillations in lasers with frequency-shifted feedback.
• Physiological role of L-type ca(2+) channels in marginal cells in the stria vascularis of Guinea pigs.
• Pro-MMP-9 is associated with poor prognosis in gastric cancer.
• Role of diacylglycerol kinase in cellular regulatory processes: a new regulator for cardiomyocyte hypertrophy.
• Serious duodenitis concomitant with graft dysfunction following renal transplantation.
• Serum carboxy-terminal telopeptide of type I collagen (ICTP) predicts cardiac events in chronic heart failure patients with preserved left ventricular systolic function.
• Successful treatment of follicular cutaneous T-cell lymphoma without mucinosis with narrow-band UVB irradiation.
• Xeroderma pigmentosum complementation group G in association with malignant melanoma.